Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Division of Chinese Internal Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan 33378, Taiwan.
Int J Mol Sci. 2023 Jun 30;24(13):10945. doi: 10.3390/ijms241310945.
Contrast-induced nephropathy (CIN) is one of the most common causes of acute kidney injury (AKI). However, management is still limited, and the cellular response to radiocontrast removal for CIN remains unclear. This study aimed to explore the latent effects of iohexol in cultured renal tubular cells with or without the removal of iohexol by medium replacement. HK2 renal tubular cells were subcultured 24 h before use in CIN experiments. Three treatment groups were established: the control, a radiocontrast (iohexol)-only group at 75 mg I/mL (I-75), and iohexol exposure for 24 h with culture medium replacement (I-75/M). Cell cycle arrest, fibrogenic mediator assays, cell viability, cell function, and cell-cycle-related protein expression were compared between groups. Iohexol induced numerous changes in HK2 renal tubular cells, such as enlarged cell shape, cell cycle arrest, increased apoptosis, and polyploidy. Iohexol inhibited the expression of cyclins, CDKs, ZO-1, and E-cadherin but conversely enhanced the expression of p21 and fibrosis-related genes, including TGF-β1, CTGF, collagen I, collagen III, and HIF-1α within 60 hr after the exposure. Except for the recovery from cell cycle arrest and cell cycle gene expression, notably, the removal of iohexol by medium replacement could not fully recover the renal tubular cells from the formation of polyploid cells, the adhesion or spreading, or the expression of fibrosis-related genes. The present study demonstrates, for the first time, that iohexol exerts latent cytotoxic effects on cultured renal tubular cells after its removal, suggesting that these irreversible cell changes may cause the insufficiency of radiocontrast reduction in CIN, which is worth investigating further.
对比剂肾病(CIN)是急性肾损伤(AKI)最常见的原因之一。然而,其治疗方法仍很有限,且 CIN 中针对造影剂去除的细胞反应仍不清楚。本研究旨在探讨在去除或不去除培养基中的碘海醇的情况下,碘海醇对培养肾小管细胞的潜在作用。在进行 CIN 实验前 24 小时,将 HK2 肾小管细胞进行传代培养。建立了 3 个处理组:对照组、仅造影剂(碘海醇)组 75mgI/mL(I-75)和碘海醇暴露 24 小时后更换培养基(I-75/M)。比较了各组之间的细胞周期停滞、纤维生成介质测定、细胞活力、细胞功能和细胞周期相关蛋白表达。碘海醇可诱导 HK2 肾小管细胞发生多种变化,如细胞形状增大、细胞周期停滞、凋亡增加和多倍体形成。碘海醇抑制细胞周期蛋白、CDK、ZO-1 和 E-钙黏蛋白的表达,但在暴露后 60 小时内相反地增强了 TGF-β1、CTGF、胶原 I、胶原 III 和 HIF-1α等纤维化相关基因的表达。除了从细胞周期停滞和细胞周期基因表达中恢复外,令人惊讶的是,通过培养基更换去除碘海醇并不能使肾小管细胞完全从多倍体细胞形成、黏附和铺展或纤维化相关基因的表达中恢复。本研究首次证明,在去除碘海醇后,碘海醇对培养的肾小管细胞仍具有潜在的细胞毒性作用,提示这些不可逆的细胞变化可能导致 CIN 中造影剂减少不足,值得进一步研究。